Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07573306 · ClinicalTrials.gov registry record
Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Cardiac Surgery Patients
A clinical trial, sponsored by University of Minnesota.
- Not yet
- Registry status
- 150
- Enrollment target
NCT07573306 is a clinical trial that has not yet begun recruiting, run by University of Minnesota. The registered enrollment target is 150 participants.
The verdict
NCT07573306 has not yet begun recruiting, sponsored by University of Minnesota.
- NOT YET RECRUITING
- Registry status
- 150 participants
- Enrollment target
Study Summary
This study will establish the feasibility and preliminary validity of real-time oxygen delivery index (DO₂i) monitoring using noninvasive hemoglobin (SpHb, Masimo) and minimally invasive cardiac output (FloTrac, Edwards) in cardiac surgery patients.
Interventions
- DEVICE SpHb monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-08-15 |
| Est. Completion | 2027-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07573306
The ClinicalTrials.gov registry entry for NCT07573306 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SpHb monitor is the first listed.
NCT07573306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07573306 about?
NCT07573306 is a clinical study titled "Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Cardiac Surgery Patients". This study will establish the feasibility and preliminary validity of real-time oxygen delivery index (DO₂i) monitoring using noninvasive hemoglobin (SpHb, Masimo) and minimally invasive cardiac output (FloTrac, Edwards) in cardiac surgery patients.
What is the current status of trial NCT07573306?
This trial is currently not yet recruiting. The enrollment target is 150 participants. The study started on 2026-08-15. Estimated completion is 2027-08-01.
What interventions are being tested in trial NCT07573306?
The interventions under investigation include: SpHb monitor (DEVICE).
Who is sponsoring clinical trial NCT07573306?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.